These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 6390386)

  • 1. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Wagstaff AJ; Benfield P; Monk JP
    Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Present and future treatment of peptic ulcer and potential role of DE-NOL.
    Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
    [No Abstract]   [Full Text] [Related]  

  • 3. [Assessment of the efficacy of de-nol and bismuth subnitrate treatment of patients with associated peptic ulcer and pyloric Helicobacter infection (experimental and clinical studies)].
    Il'chenko AA; Zurabishvili NG; Zhukhovitskiĭ BG; Gorodinskaia VS
    Ter Arkh; 1991; 63(2):21-6. PubMed ID: 2048016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De-Nol: a new concept in cytoprotection. Proceedings from an international symposium. Milan, Italy, 13 November 1985.
    Scand J Gastroenterol Suppl; 1986; 122():1-53. PubMed ID: 3465025
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of the efficacy of De-Nol and ranitidine in treating duodenal ulcer].
    Oproiu A; Pospai D; Cociaşu S; Oproiu C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(4):375-84. PubMed ID: 2905519
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
    Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
    Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of De-Nol].
    Tomecki R; Habior A; Medrzejewski W
    Pol Tyg Lek; 1984 Sep; 39(37):1247-8. PubMed ID: 6390386
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of peptic ulcer. Bismuth salts].
    Börsch G
    Verh Dtsch Ges Inn Med; 1988; 94():284-92. PubMed ID: 3061197
    [No Abstract]   [Full Text] [Related]  

  • 9. [Colloidal bismuth subcitrate (de-nol) in the treatment of peptic ulcer].
    Grigo'rev PIa; Isakov VA; Iakovenko EP
    Klin Med (Mosk); 1989 May; 67(5):17-22. PubMed ID: 2671482
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progress in the pharmacotherapy of peptic ulcer].
    Stasiewicz J; Moniuszko-Jakoniuk J
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1721-5. PubMed ID: 6151657
    [No Abstract]   [Full Text] [Related]  

  • 11. [Selective and locally-acting drugs in the treatment of peptic ulcer].
    Ryss ES
    Klin Med (Mosk); 1984 Jul; 62(7):10-8. PubMed ID: 6384654
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gastroduodenal ulcer and Campylobacter pylori. Behavior under treatment with de-nol or metronidazole].
    Velasco Elizalde C; Quintero Díaz M; Soto Escobar A; Buesa Muñoz F; González Cansino J; Haedo Quiñones W
    G E N; 1987; 41(3):99-103. PubMed ID: 3149943
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.